A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...

Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...

Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...

SAN FRANCISCO -- Treatment with intensity-modulated proton therapy (IMPT) or intensity-modulated radiation therapy (IMRT) ...

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in the United States, ...

Stereotactic body radiation therapy (SBRT), defined as the delivery of >5Gy per fraction, has emerged as a well-established standard of care option for the definitive management of localized prostate ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...